Lecture Details - Table of Contents
This activity is part of PER's Integrated Oncology Learning Series:
A Focus on Chronic Lymphocytic Leukemia
Defining a Standard of Care for Indolent NHL and CLL: A 2009 Perspective
Release Date: June 25, 2009| Jun 23, 2009, Kohala Coast, HI
Table of Contents
Treatment Options for a Patient With FL: Current Standards of Care and Future Directions
Bruce D. Cheson
Decision Points in the Management of a Patient With MCL
John P. Leonard
Practical Considerations for Patients With CLL
Susan O’Brien
Instructions for Participation
To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>
To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>
This minisymposium was held in conjunction with the 2009 Pan Pacific Lymphoma Conference.
Read all of the conditions in the Activity Terms box below. You must accept the Activity Terms in order to continue:
Disclaimer
Physicians’ Education Resource presents this resource for educational purposes only. Participants are expected to use their own expertise and judgment while engaged in the practice of medicine. Please consult full prescribing information for any drugs or procedures discussed within.
The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this publication to ensure accuracy, the authors and Physicians’ Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.
Disclosure of Unlabeled Uses
This reference may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physician’s Desk Reference.
All rights reserved; for personal use only. No part of this presentation may be translated, reproduced or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.
Software Requirements
The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.
If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.
PC UsersIf you need to upgrade your Web browser, follow one of the links listed below:
- Microsoft Internet Explorer Downloads (Outside Source)
- Mozilla Firefox Product Page (Outside Source)
- Adobe Flash Player 9 (Outside Source)
- ITunes for Podcast (Outside Source)
- Adobe Acrobat Reader (Outside Source)
Macintosh Users
Compatible Web browsers include
- Firefox (Outside Source)
- Apple Safari (Outside Source).
- Adobe Flash Player 9 (Outside Source)
- ITunes for Podcast (Outside Source)
- Adobe Acrobat Reader (Outside Source)
Educational Grants
An educational grant for this activity was provided by:
- GlaxoSmithKline
- Cephalon Oncology